GSK Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA7098380
EBIT4587810
Earning Per Share212236
Expenses2,5042,5162,447
Net Profit3581,695611
Net Profit Margin111219
Operating Profit Margin252628
Profit Before Tax551779836
Dividends Per Share30900
Operation Revenue3,3093,3543,352

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of GSK Pharma is 0 as of 2/22/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20052005200520052023
Operating Activities349349349349484
Investing Activities71717171808
Financing Activities-444-444-444-444-1,543
Others00000
Net Cash Flow-24-24-24-24-251

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of GSK Pharma is 484 as of 2/22/2024